Cns Pharmaceuticals Inc (NASDAQ:CNSP) has a beta value of 1.05 and has seen 13.24 million shares traded in the last trading session. The CNSP stock price is -124900.0% off its 52-week high price of $137.50 and 9.09% above the 52-week low of $0.10. If we look at the company’s 10-day average daily trading volume, we find that it stood at 73.93 million shares traded. The 3-month trading volume is 14.52 million shares.
Cns Pharmaceuticals Inc (NASDAQ:CNSP) trade information
Sporting 0.90% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the CNSP stock price touched $0.11 or saw a rise of 31.25%. Year-to-date, Cns Pharmaceuticals Inc shares have moved -99.82%, while the 5-day performance has seen it change -14.83%. Over the past 30 days, the shares of Cns Pharmaceuticals Inc (NASDAQ:CNSP) have changed -6.24%. Short interest in the company has seen 1.11 million shares shorted with days to cover at 0.98.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Wall Street analysts have a consensus price target for the stock at $0.5, which means that the shares’ value could jump 78.0% from current levels. The projected low price target is $0.5 while the price target rests at a high of $0.5. In that case, then, we find that the current price level is -354.55% off the targeted high while a plunge would see the stock gain -354.55% from current levels.
Cns Pharmaceuticals Inc (CNSP) estimates and forecasts
The company’s shares have lost -98.98% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 17.98% over the past 5 years.
CNSP Dividends
Cns Pharmaceuticals Inc is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Cns Pharmaceuticals Inc (NASDAQ:CNSP)’s Major holders
Insiders own 1.21% of the company shares, while shares held by institutions stand at 0.29% with a share float percentage of 0.29%. Investors are also buoyed by the number of investors in a company, with Cns Pharmaceuticals Inc having a total of 11.0 institutions that hold shares in the company.
